Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer

被引:42
|
作者
Kreymborg, Katharina [1 ,2 ]
Haak, Stefan [3 ,4 ,5 ]
Murali, Rajmohan [6 ,7 ]
Wei, Joyce [8 ]
Waitz, Rebecca [1 ,2 ]
Gasteiger, Georg [1 ,2 ]
Savage, Peter A. [9 ]
van den Brink, Marcel R. M. [10 ]
Allison, James P. [1 ,2 ,8 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Program Immunol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, New York, NY 10021 USA
[3] Columbia Univ, Med Ctr, New York, NY USA
[4] Tech Univ Munich, Ctr Allergy & Environm ZAUM, D-80290 Munich, Germany
[5] Helmholtz Ctr Munich, Munich, Germany
[6] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
[8] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
[9] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[10] Mem Sloan Kettering Canc Ctr, Dept Immunol & Med, New York, NY 10021 USA
基金
瑞士国家科学基金会;
关键词
REGULATORY T-CELLS; IFN-GAMMA; B7; FAMILY; EXPRESSION; IMMUNOTHERAPY; MEMBER; MOUSE;
D O I
10.1158/2326-6066.CIR-15-0100
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The costimulatory molecules B7-H3 and B7-H4 are over-expressed in a variety of human tumors and have been hypothesized as possible biomarkers and immunotherapeutic targets. Despite this potential, the predominating uncertainty about their functional implication in tumor-host interaction hampers their evaluation as a target for cancer therapy. By means of a highly physiologic, spontaneous tumor model in mice, we establish a causal link between B7-H3 and host tumor control and found B7-H4 to be redundant.
引用
收藏
页码:849 / 854
页数:6
相关论文
共 50 条
  • [31] B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes
    Altan, Mehmet
    Pelekanou, Vasiliki
    Schalper, Kurt A.
    Toki, Maria
    Gaule, Patricia
    Syrigos, Konstantinos
    Herbst, Roy S.
    Rimm, David L.
    CLINICAL CANCER RESEARCH, 2017, 23 (17) : 5202 - 5209
  • [32] B7-H3: a robust target for immunotherapy in prostate cancer
    Pulido, Rafael
    Lopez, Jose I.
    Nunes-Xavier, Caroline E.
    TRENDS IN CANCER, 2024, 10 (07) : 584 - 587
  • [33] B7-H3 immune checkpoint molecule in prostate cancer
    Ntala, C.
    Salmond, J.
    Blomme, A.
    Ahmad, I.
    Leung, H.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S168 - S169
  • [34] B7-H3 as a therapeutic target in prostate cancer.
    Guo, Christina
    Figueiredo, Ines
    Gurel, Bora
    Crespo, Matues
    Rekowski, Jan
    Carreira, Suzanne
    Neeb, Antje
    Sharp, Adam
    de la Maza, Maria D. Fenor
    Rescigno, Pasquale
    Chandran, Khobe
    Ferreira, Ana
    Riisnaes, Ruth
    Miranda, Susana
    Pereira, Rita
    Gil, Veronica
    Seed, George
    Bertan, Claudia
    Baker, Chloe
    Yuan, Wei
    de Bono, Johann S.
    CANCER RESEARCH, 2021, 81 (13)
  • [35] High B7-H3 expression is linked to increased risk of prostate cancer progression
    Bonk, Sarah
    Tasdelen, Pinar
    Kluth, Martina
    Hube-Magg, Claudia
    Makrypidi-Fraune, Georgia
    Moeller, Katharina
    Hoeflmayer, Doris
    Rico, Sebastian Dwertmann
    Buescheck, Franziska
    Minner, Sarah
    Heinzer, Hans
    Graefen, Markus
    Hinsch, Andrea
    Luebke, Andreas M.
    Dum, David
    Uhlig, Ria
    Schlomm, Thorsten
    Sauter, Guido
    Simon, Ronald
    Weideman, Soeren A.
    PATHOLOGY INTERNATIONAL, 2020, 70 (10) : 733 - 742
  • [36] B7-H3 is related to tumor progression in ovarian cancer
    Zhang, Jingjing
    Liu, Lu
    Han, Sai
    Li, Yi
    Qian, Qiuhong
    Zhang, Qianqian
    Zhang, Hui
    Yang, Ziyan
    Zhang, Youzhong
    ONCOLOGY REPORTS, 2017, 38 (04) : 2426 - 2434
  • [37] Expressions of B7-H4 and B7-H3 Proteins and Effect of Sorafenib on their Expressions in Different Human Hepatoma Cell Lines
    Shen, Ya-Ping
    Zhang, Shuai
    Wang, Li-Zhou
    Yang, Xi-Yuan
    Liu, Wei-Xin
    Long, Ji-Fu
    Zhou, Shi
    Li, Kun
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2015, 14 (10) : 1797 - 1802
  • [38] RETRACTION: The Coexpression and Clinical Significance of Costimulatory Molecules B7-H1, B7-H3, and B7-H4 in Human Pancreatic Cancer (Retraction of Vol 7, Pg 1465, 2014)
    Chen, Y.
    Sun, J.
    Zhao, H.
    ONCOTARGETS AND THERAPY, 2022, 15 : 699 - 699
  • [39] B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression
    Yuan, Hexing
    Wei, Xuedong
    Zhang, Guangbo
    Li, Chen
    Zhang, Xueguang
    Hou, Jianquan
    JOURNAL OF UROLOGY, 2011, 186 (03): : 1093 - 1099
  • [40] B7-H4 is highly expressed in ductal and lobular breast cancer
    Tringler, B
    Zhuo, SQ
    Pilkington, G
    Torkko, KC
    Singh, M
    Lucia, MS
    Heinz, DE
    Papkoff, J
    Shroyer, KR
    CLINICAL CANCER RESEARCH, 2005, 11 (05) : 1842 - 1848